We are live on ! Find out more

3,820 hedge funds and large institutions have $253B invested in Merck in 2026 Q2 according to their latest regulatory filings, with 209 funds opening new positions, 1,628 increasing their positions, 1,491 reducing their positions, and 117 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more first-time investments, than exits

New positions opened: 209 | Existing positions closed: 117

8% more capital invested

Capital invested by funds: $234B → $253B (+$19.7B)

1.83% more ownership

Funds ownership: 78.1%79.93% (+1.8%)

9% more repeat investments, than reductions

Existing positions increased: 1,628 | Existing positions reduced: 1,491

1% more funds holding

Funds holding: 3,7963,820 (+24)

0% less call options, than puts

Call options by funds: $3.18B | Put options by funds: $3.18B

12% less funds holding in top 10

Funds holding in top 10: 8978 (-11)

Holders
3,820
Holders Change
+24
Holders Change %
+0.63%
% of All Funds
46.14%
Holding in Top 10
78
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-12.36%
% of All Funds
0.94%
New
209
Increased
1,628
Reduced
1,491
Closed
117
Calls
$3.18B
Puts
$3.18B
Net Calls
-$2.75M
Net Calls Change
-$654M
Name Holding Trade Value Shares
Change
Change in
Stake
CA
1251
CGN Advisors
Kansas
$3.56M -$76.5K -654 -2%
TAM
1252
Trust Asset Management
Texas
$3.55M -$52.4K -448 -2%
CIS
1253
Capital International Sarl
California
$3.55M +$3.23M +27,611 New
EIA
1254
Emerald Investment Advisers
Pennsylvania
$3.55M +$92.2K +788 +3%
DEA
1255
DoubleLine ETF Adviser
Florida
$3.54M -$396K -3,383 -11%
IIC
1256
Integrated Investment Consultants
Michigan
$3.53M -$5.74K -49 -0.2%
WIS
1257
Wright Investors Service
Connecticut
$3.52M -$59.2K -506 -2%
ACS
1258
Archford Capital Strategies
Illinois
$3.52M -$818K -6,991 -20%
SSA
1259
SSA Swiss Advisors
$3.51M -$1.26M -10,750 -28%
SAS
1260
Stelac Advisory Services
New York
$3.51M -$1.26M -10,750 -28%
WC
1261
Waterloo Capital
Texas
$3.51M +$27.9K +238 +0.9%
NERM
1262
New England Research & Management
Illinois
$3.51M +$87.8K +750 +3%
EL
1263
Essex LLC
Illinois
$3.5M +$72.2K +617 +2%
PWW
1264
Pettyjohn Wood & White
Virginia
$3.5M -$46.2K -395 -1%
WPC
1265
Wedmont Private Capital
Pennsylvania
$3.49M +$284K +2,429 +9%
PCG
1266
Prosperity Consulting Group
Maryland
$3.49M +$181K +1,550 +6%
FGP
1267
Freestone Grove Partners
California
$3.49M +$3.18M +27,158 New
CC
1268
Chicago Capital
Illinois
$3.48M +$6.44K +55 +0.2%
HAS
1269
HBW Advisory Services
California
$3.47M +$14.9K +127 +0.5%
WBWA
1270
William B. Walkup & Associates
South Carolina
$3.47M +$37K +316 +1%
TPWA
1271
TRUE Private Wealth Advisors
Oregon
$3.47M -$160K -1,368 -5%
ANBT
1272
American National Bank & Trust
Texas
$3.47M
VIA
1273
Victrix Investment Advisors
Florida
$3.46M +$263K +2,244 +9%
VA
1274
Valmark Advisers
Ohio
$3.46M -$169K -1,442 -5%
MSFS
1275
Main Street Financial Solutions
Pennsylvania
$3.45M +$31.8K +272 +1%

MRK Hedge Fund Activity: Q2 2026 in Review

3,820 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2026, worth a combined $253B — up 8.4% from $234B a quarter earlier.

Buyers outnumbered sellers: 209 funds opened new MRK positions and 117 closed out — a net gain of 92 holders — while 1,628 added to existing stakes and 1,491 trimmed.

The largest buyer was Capital International Investors, adding an estimated $1.7B. The largest seller was JP Morgan Chase, cutting an estimated $1.06B.

  • 3,820 institutional investors held Merck (MRK) as of Q2 2026, up from 3,796 in Q1 2026.
  • Funds reported $253B of Merck stock for Q2 2026, up 8.4% quarter-over-quarter.
  • 209 funds opened new Merck positions in Q2 2026 and 117 closed out, a net change of +92 holders.
  • The largest Merck buyer in Q2 2026 was Capital International Investors, an estimated $1.7B added.
  • The largest Merck seller in Q2 2026 was JP Morgan Chase, an estimated $1.06B sold.

Based on aggregated 13F filings for Q2 2026.